Pharvaris N.V.
(PHVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 303,776 | 423,430 | 170,512 | 247,686 | 112,664 |
| Receivables | 3,186 | 1,125 | 403 | 828 | 651 |
| Income taxes - deferred | N/A | N/A | N/A | 204 | 114 |
| Other current assets | 6,219 | 6,040 | 4,875 | 1,791 | 2,003 |
| TOTAL | $313,181 | $430,595 | $175,790 | $250,508 | $115,431 |
| Non-Current Assets | |||||
| PPE Net | 722 | 242 | 204 | 128 | 55 |
| Other Non-Current Assets | 1,394 | 670 | 730 | 288 | 0 |
| TOTAL | $2,116 | $913 | $934 | $416 | $55 |
| Total Assets | $315,297 | $431,507 | $176,724 | $250,924 | $115,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,938 | 3,149 | 7,043 | 2,947 | 968 |
| Accrued Expenses | 19,032 | 11,978 | 11,475 | 5,052 | 5,103 |
| TOTAL | $24,861 | $15,804 | $19,201 | $8,265 | $6,070 |
| Non-Current Liabilities | |||||
| TOTAL | $692 | $47 | $263 | $178 | $N/A |
| Total Liabilities | $25,553 | $15,851 | $19,464 | $8,444 | $6,070 |
| Shareholders' Equity | |||||
| Common Shares | 7,061 | 6,791 | 4,276 | 4,707 | 269 |
| Retained earnings | -435,280 | -287,804 | -172,989 | -103,602 | -50,787 |
| Other shareholders' equity | 43,121 | 30,175 | 21,296 | 11,595 | 2,257 |
| TOTAL | $289,744 | $415,656 | $157,259 | $242,480 | $109,416 |
| Total Liabilities And Equity | $315,297 | $431,507 | $176,724 | $250,924 | $115,486 |